Observational study of iris tumors using imaging techniques

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study utilizes Optical Coherence Tomography (OCT) angiography to characterize melanotic and amelanotic iris tumors by comparing imaging data from affected eyes to healthy controls. The study aims to enhance understanding of iris tumors and their vascular characteristics. Participants include individuals diagnosed with iris tumors as well as healthy individuals without any iris lesions. The study will not involve any treatments or interventions, focusing solely on data collection and analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria for tumor group:

* Eyes with diagnosis of melanotic or amelanotic iris tumors

Inclusion Criteria for healthy control group:

* Eyes without iris defects or lesions

Exclusion Criteria (both groups):

* Inability to give informed consent
* Inability to maintain stable fixation for OCT imaging
* Inability to commit to required study visits
* Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
* Mature cataracts if found to limit visual potential to worse than 20/40

Where it's running

• Oregon Health & Science University
  Portland, Oregon, United States Recruiting

Study contacts

• Principal investigator: David Huang, MD, PhD — Oregon Health and Science University
• Study coordinator: Denzil Romfh, OD
• Email: romfhd@ohsu.edu
• Phone: 503-494-4351

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Topical ruxolitinib for adults with pyoderma gangrenosum

  This pilot study tests a topical cream of ruxolitinib to see if it helps heal PG ulcers in adults without adding systemic immunosuppressants.

  Recruiting Phase 2 Oregon Health and Science University · Portland, Oregon · NCT07783412

• Bright light therapy to help sleep after brain injury

  This trial tests whether morning bright light therapy can improve sleep and related brain health markers in adults with a traumatic brain injury.

  Recruiting Oregon Health and Science University · Portland, Oregon · NCT07601841

• Transitioning from mavacamten to aficamten in obstructive HCM

  This study tests whether switching from mavacamten to aficamten is feasible and safe for people with obstructive hypertrophic cardiomyopathy who are already on mavacamten.

  Recruiting Phase 4 Oregon Health and Science University · Kansas City, Missouri and 1 other locations · NCT07600177

• Motor Activation Therapy after concussion: a targeted rehabilitation approach

  This study tests a motor-activation focused physical therapy for people with persistent balance problems after a concussion to see if it improves their responses to imbalance.

  Recruiting at 2 sites Oregon Health and Science University · Portland, Oregon and 1 other locations · NCT07549529

• L-fucose supplementation for adults with GLUT1 deficiency

  This trial will test whether taking L-fucose supplements helps reduce ataxia and other symptoms in adults with GLUT1 deficiency.

  Recruiting Phase 2 Oregon Health and Science University · Portland, Oregon · NCT07432490

• Cefotetan Therapy for E. coli Infections

  This pilot study tests whether cefotetan works for bloodstream infections caused by E. coli, compared with standard antibiotics, to see if it improves outcomes.

  Recruiting Phase 2 Oregon Health and Science University · Portland, Oregon · NCT07318584

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.